21447/34351US=35 / Biol/Mol
Morton CL, Houghton PJ. Animal models to predict anticancer efficacy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 539-45. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; EXPERIMENTOS


21448/34351US=35 / Biol/Mol
Collins JM. Pharmacokinetics, pharmacodynamics, and pharmacogenetics. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 547-52. ISBN 978-1-4160-3703-3.

FARMACOCINETICA; FARMACODINAMICA; FARMACOGENETICA


21449/34351US=35 / Biol/Mol
LoRusso PM, Bekele BN, Boerner SA, Davis DW, Evelhoch JL, Herbst RS. Phase 1 trials today. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 553-70. ISBN 978-1-4160-3703-3.

ENSAIOS CLINICOS; MARCADORES FARMACODINAMICOS


21450/34351US=35 / Biol/Mol
Hait WN, Rubin E, Bertino JR. Cancer therapeutics. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 571-81. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; TERAPEUTICOS; INDICE TERAPEUTICO; DROGAS


21451/34351US=35 / Biol/Mol
Sikic BI. Natural and acquired resistance to cancer therapies. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 583-92. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; RESISTENCIA NATURAL; RESISTENCIA ADQUIRIDA; FALHA NO TRATAMENTO; RESISTENCIA A DROGAS


21452/34351US=35 / Biol/Mol
Woodward WA, Cox JD. Molecular basis of radiation therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 593-604. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; RADIOTERAPIA; MORTE CELULAR; RADIOBIOLOGIA TRANSLATIONAL


21453/34351US=35 / Biol/Mol
Ekmekcioglu S, Kurzrock R, Grimm EA. Hematopoietic growth factors and cytokines. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 605-19. ISBN 978-1-4160-3703-3.

FATORES DE CRESCIMENTO HEMATOPOIETICOS; CITOCINAS; ERITROPOIETINA; GRANULOCITOS; MACROFAGOS; TROMBOPOIETINA; INTERLEUCINA


21454/34351US=35 / Biol/Mol
Borden EC, Silverman RH, Sen G. Interferons. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 621-33. ISBN 978-1-4160-3703-3.

INTERFERONS; ACAO ANTITUMOR


21455/34351US=35 / Biol/Mol
Liu YJ, Hwu P. Cancer and the cellular immune response. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 635-47. ISBN 978-1-4160-3703-3.

CANCER; RESPOSTA IMUNE CELULAR; CELULAS T REGULATORIAS; AUTOIMUNIDADE; IMUNIDADE ANTITUMOR; VACINAS; CITOCINAS; IMUNOTERAPIA


21456/34351US=35 / Biol/Mol
Pardoll DM. Cancer-specific vaccines. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 649-69. ISBN 978-1-4160-3703-3.

CANCER; VACINAS; ANTIGENOS TUMORAIS; VACINAS TUMORAIS DE CELULAS INTEIRAS; VACINAS TUMORAIS MODIFICADAS GENETICAMENTE; VACINAS ESPECIFICAS PARA O ANTIGENO; VACINACAO COM A PROTEINA DE CHOQUE TERMICO HSP


21457/34351US=35 / Biol/Mol
Posada JG Jr, Frankel AE. Monoclonal antibody therapy of cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 671-8. ISBN 978-1-4160-3703-3.

CANCER. TERAPIA; ANTICORPOS MONOCLONAIS


21458/34351US=35 / Biol/Mol
McCormick F, Korn WM. Gene therapy and oncolytic viruses. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 679-90. ISBN 978-1-4160-3703-3.

VIRUS ONCOLITICOS; TERAPIA GENETICA; MORTE DAS CELULAS CANCERIGENAS


21459/34351US=35 / Biol/Mol
Calin GA, Croce CM. RNA as a therapeutic molecule. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 691-9. ISBN 978-1-4160-3703-3.

MOLECULA DE RNA TERAPEUTICO


21460/34351US=35 / Biol/Mol
Neckers L. Heat shock protein 90 and the proteasome: housekeeping proteins become novel molecular targets for cancer therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 701-10. ISBN 978-1-4160-3703-3.

PROTEINA DE CHOQUE TERMICO 90; PROTEASSOMA; ALVOS MOLECULARES; CANCER. TERAPIA; HSP90


21461/34351US=23 / Câncer
Raymond JS, Hogue CJR. Are breast cancer survivors at risk for developing other cancers?. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 589-600. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; SOBREVIVENCIA; DESENVOLVIMENTO DE CANCER


21462/34351US=35 / Biol/Mol
Lippman SM, Lee JJ. Cancer chemoprevention. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 711-20. ISBN 978-1-4160-3703-3.

CANCER; QUIMIOPREVENCAO; PREVENCAO MOLECULAR-ALVO; BIOMARCADORES


21463/34351US=23 / Câncer
Chagpar AB. Distant metastasis in elderly patients with breast cancer: prognosis with nodal status. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 601-8. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; METASTASES; PACIENTES IDOSOS; PROGNOSTICO; STATUS NODAL; AVALIACAO DO LINFONODO


21464/34351US=23 / Câncer
Azria D, Belkacemi Y, Gligorov J, Ozsahin M. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 609-23. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TAMOXIFENO; RADIOTERAPIA; FIBROSE SUBCUTANEA; HIPERSENSIBILIDADE


21465/34351US=23 / Câncer
Brown AP, Gaffney DK, Macdonald OK. Malignant phyllodes tumor of the breast: is adjuvant radiotherapy necessary?. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 625-35. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; RADIOTERAPIA; TUMOR PHYLLODES. APRESENTACAO CLINICA; TUMOR PHYLLODES. DIAGNOSTICO; TUMOR PHYLLODES. PROGNOSTICO; TUMOR PHYLLODES. TRATAMENTO


21466/34351US=23 / Câncer
Atalay C. Locally advanced breast cancer: multidrug resistance. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 637-52. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA LOCALMENTE AVANCADO; MULTIRRESISTENCIA; QUIMIOTERAPIA


Primeira | Anterior | Próxima | Última